Morgan Stanley Downgrades Teva Pharma (TEVA) to Equalweight

Morgan Stanley downgraded Teva Pharma (NASDAQ: TEVA) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $45.71 yesterday, with a 52 week range of $35.00-$54.99.

---

Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40
• Goldman Sachs Cuts Numbers on Tiffany & Co. (TIF) after Weak Q1, Guidance
• UBS Maintains a 'Neutral' on VeriFone (PAY); Europe Demand Healthy, but FX Emerges as Headwind

Create E-mail Alert Related Categories

Downgrades

Related Entities

Morgan Stanley

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter